WG

GeneDx Holdings Corp.

WGS ·

GeneDx Holdings Corp. (WGS) is a Medical healthcare information services company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for GeneDx Holdings Corp. in 2026. The next earnings report is expected on November 3, 2026.

Earnings calendar

Next earnings date

03 Nov 2026

In 75 days

EPS estimate

0.10

Revenue estimate

126.1M

Past earnings

03 Aug 2026
EPS actual
0.01 (+105.3%)
estimate -0.19
Revenue actual
114.4M (+3.1%)
estimate 111.0M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
04 May 2026
EPS actual
-0.28 (-1,766.7%)
estimate -0.02
Revenue actual
102.3M (-9.1%)
estimate 112.5M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
23 Feb 2026
EPS actual
0.14 (+36.8%)
estimate 0.10
Revenue actual
121.0M (+0.6%)
estimate 120.3M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
Beat Miss usd

Latest earnings analysis

GeneDx Holdings Corp. beat consensus estimates in its latest earnings report, with EPS of USD 0.01 versus an estimate of USD -0.1879 and revenue of USD 114.44 million exceeding estimates by 3.1%. In the prior quarter, both EPS and revenue came in below expectations.

Dividend calendar

No dividend history available.

EPS (Earnings Per Share)

Revenue

Company profile

GeneDx Holdings Corp. is a patient centered health intelligence company. It engages in transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. The firm, through its Centrellis health intelligence platform, generates a more complete understanding of disease and wellness and provides science-driven solutions to the most pressing medical needs. The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, CT.

Sector
Healthcare
Industry
Medical healthcare information services
Country
United States
Exchange
Nasdaq
CEO
Katherine A. Stueland
Employees
1,000
IPO date
04 Nov 2020
ISIN
US81663L2007
Website
genedx.com

Frequently asked questions

When does GeneDx Holdings Corp. (WGS) next report earnings?

GeneDx Holdings Corp. (WGS) is scheduled to report earnings on November 3, 2026.

What was GeneDx Holdings Corp.'s most recent earnings date?

GeneDx Holdings Corp. (WGS) last reported earnings on August 3, 2026.

Where is GeneDx Holdings Corp. stock listed?

GeneDx Holdings Corp. (WGS) is listed on Nasdaq.